Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey
- 1 August 2023
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 24 (13) , 725-730
Abstract
Background: ALK rearrangements account for around 5% of non-small-cell lung cancers. Aim: This study surveys physicians on the potential efficacy of a mobile application in improving the management...Keywords
This publication has 23 references indexed in Scilit:
- Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non–Small Cell Lung CancerAmerican Journal of Roentgenology, 2019
- Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapiesOncotarget, 2017
- The use of a smartphone application for fast lung cancer risk assessment†European Journal of Cardio-Thoracic Surgery, 2017
- Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitorsClinical Epidemiology, 2014
- ALK-rearrangements and testing methods in non-small cell lung cancer: a reviewGenes & Cancer, 2014
- Crizotinib versus Chemotherapy in AdvancedALK-Positive Lung CancerNew England Journal of Medicine, 2013
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendationsVirchows Archiv, 2012
- Lung Cancer: Epidemiology, Etiology, and PreventionClinics in Chest Medicine, 2011
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Classification, staging and prognosis of lung cancerEuropean Journal of Radiology, 2003